A detailed history of Pinnacle Financial Partners Inc transactions in Dexcom Inc stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 51,949 shares of DXCM stock, worth $3.94 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
51,949
Previous 53,375 2.67%
Holding current value
$3.94 Million
Previous $6.05 Million 42.47%
% of portfolio
0.07%
Previous 0.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$64.0 - $116.06 $91,264 - $165,501
-1,426 Reduced 2.67%
51,949 $3.48 Million
Q2 2024

Aug 06, 2024

BUY
$110.31 - $140.45 $186,644 - $237,641
1,692 Added 3.27%
53,375 $6.05 Million
Q1 2024

Apr 30, 2024

BUY
$114.22 - $140.1 $212,563 - $260,726
1,861 Added 3.74%
51,683 $7.17 Million
Q4 2023

Jan 22, 2024

SELL
$75.49 - $124.16 $238,472 - $392,221
-3,159 Reduced 5.96%
49,822 $6.18 Million
Q3 2023

Nov 03, 2023

BUY
$86.06 - $137.93 $423,329 - $678,477
4,919 Added 10.23%
52,981 $4.94 Million
Q2 2023

Aug 07, 2023

SELL
$112.47 - $130.98 $2.42 Million - $2.82 Million
-21,507 Reduced 30.91%
48,062 $6.18 Million
Q1 2023

Apr 26, 2023

BUY
$104.0 - $122.92 $764,088 - $903,093
7,347 Added 11.81%
69,569 $8.08 Million
Q4 2022

Feb 03, 2023

BUY
$84.98 - $122.67 $2.57 Million - $3.71 Million
30,216 Added 94.41%
62,222 $7.05 Million
Q3 2022

Oct 31, 2022

BUY
$76.35 - $94.18 $61,919 - $76,379
811 Added 2.6%
32,006 $2.58 Million
Q2 2022

Jul 29, 2022

BUY
$67.99 - $132.89 $1.63 Million - $3.18 Million
23,936 Added 329.74%
31,195 $2.33 Million
Q1 2022

May 02, 2022

BUY
$94.08 - $130.2 $635,886 - $880,021
6,759 Added 1351.8%
7,259 $3.71 Million
Q4 2021

Feb 01, 2022

BUY
$129.87 - $162.82 $64,935 - $81,410
500 New
500 $268,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Pinnacle Financial Partners Inc Portfolio

Follow Pinnacle Financial Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.